Welcome to LookChem.com Sign In|Join Free
  • or
7-chloro-N-(4-chlorophenyl)quinolin-4-amine is a quinoline derivative with the molecular formula C15H9Cl2N3, featuring both chlorine and amine groups in its structure. It is a versatile chemical compound commonly used in medicinal chemistry as a building block for the synthesis of pharmaceuticals and agrochemicals. Its potential biological activities include antimalarial, anticancer, anti-inflammatory, and antimicrobial properties, making it a promising candidate for various applications in science and medicine.

5431-39-0

Post Buying Request

5431-39-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5431-39-0 Usage

Uses

Used in Pharmaceutical Industry:
7-chloro-N-(4-chlorophenyl)quinolin-4-amine is used as a key intermediate in the synthesis of various pharmaceuticals for its potential biological activities, such as antimalarial and anticancer properties. Its unique structure allows for the development of new drugs targeting specific diseases.
Used in Agrochemical Industry:
7-chloro-N-(4-chlorophenyl)quinolin-4-amine is used as a building block in the synthesis of agrochemicals, contributing to the development of effective pesticides and other agricultural products.
Used in Antimalarial Applications:
7-chloro-N-(4-chlorophenyl)quinolin-4-amine is studied for its potential antimalarial properties, offering a new avenue for the development of treatments against malaria.
Used in Anticancer Applications:
7-chloro-N-(4-chlorophenyl)quinolin-4-amine is investigated for its anticancer properties, with the potential to be developed into new therapeutic agents for the treatment of various types of cancer.
Used in Anti-inflammatory Applications:
7-chloro-N-(4-chlorophenyl)quinolin-4-amine is studied for its anti-inflammatory properties, which may lead to the development of new treatments for inflammatory diseases.
Used in Antimicrobial Applications:
7-chloro-N-(4-chlorophenyl)quinolin-4-amine is researched for its antimicrobial properties, potentially contributing to the development of new antibiotics and antifungal agents to combat drug-resistant infections.

Check Digit Verification of cas no

The CAS Registry Mumber 5431-39-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,4,3 and 1 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 5431-39:
(6*5)+(5*4)+(4*3)+(3*1)+(2*3)+(1*9)=80
80 % 10 = 0
So 5431-39-0 is a valid CAS Registry Number.

5431-39-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 7-chloro-N-(4-chlorophenyl)quinolin-4-amine

1.2 Other means of identification

Product number -
Other names (7-Chlor-[4]chinolyl)-(4-chlor-phenyl)-amin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5431-39-0 SDS

5431-39-0Downstream Products

5431-39-0Relevant academic research and scientific papers

Preparation method of intermediate for leukemia treatment medicines

-

Paragraph 0071; 0072; 0073; 0074; 0075, (2019/01/23)

The invention belongs to the technical field of chemical medicines, and specifically relates to a preparation method of an intermediate for leukemia treatment medicines. The method comprises the stepsof supporting N-[3-(triethoxysilyl)propyl]-4,5-dihydroi

Trifluoroacetic acid in 2,2,2-trifluoroethanol facilitates SNAr reactions of heterocycles with arylamines

Carbain, Benoit,Coxon, Christopher R.,Lebraud, Honorine,Elliott, Kristopher J.,Matheson, Christopher J.,Meschini, Elisa,Roberts, Amy R.,Turner, David M.,Wong, Christopher,Cano, Celine,Griffin, Roger J.,Hardcastle, Ian R.,Golding, Bernard T.

supporting information, p. 2311 - 2317 (2014/03/21)

Small-molecule drug discovery requires reliable synthetic methods for attaching amino compounds to heterocyclic scaffolds. Trifluoroacetic acid-2,2,2-trifluoroethanol (TFA-TFE) is as an effective combination for achieving SNAr reactions between

Structural optimization of quinolon-4(1 H)-imines as dual-stage antimalarials: Toward increased potency and metabolic stability

Ressurrei??o, Ana S.,Gon?alves, Daniel,Sitoe, Ana R.,Albuquerque, Ine?s S.,Gut, Jiri,Góis, Ana,Gon?alves, Lídia M.,Bronze, Maria R.,Hanscheid, Thomas,Biagini, Giancarlo A.,Rosenthal, Philip J.,Prude?ncio, Miguel,O'Neill, Paul,Mota, Maria M.,Lopes, Francisca,Moreira, Rui

supporting information, p. 7679 - 7690 (2013/11/06)

Discovery of novel effective and safe antimalarials has been traditionally focused on targeting erythrocytic parasite stages that cause clinical symptoms. However, elimination of malaria parasites from the human population will be facilitated by intervent

Microwave-accelerated solvent- and catalyst-free synthesis of 4-aminoaryl/alkyl-7-chloroquinolines and 2-aminoaryl/alkylbenzothiazoles

Motiwala, Hashim F.,Kumar, Raj,Chakraborti, Asit K.

, p. 369 - 374 (2008/02/11)

An efficient synthesis of 4-aminoaryl/alkyl-7-chloroquinolines and 2-aminoaryl/alkylbenzothiazoles has been developed by microwave-accelerated regioselective aromatic nucleophilic substitution of 4,7-dichloroquinoline and 2-chlorobenzothiazole with aromatic and aliphatic amines under solvent-free conditions in the absence of any added protic or Lewis acid catalyst. Chemoselective reaction with the amino group in preference to the phenolic hydroxy group was observed. Thus, the treatment of 4,7-dichloroquinoline (1 equiv.) with a mixture of aniline (2 equiv.) and phenol (2 equiv.) afforded exclusive formation of 4-aminophenyl-7-chloroquinoline. When 4,7-dichloroquinoline (1 equiv.) was separately treated with 2-aminophenol (2 equiv.) and 4-aminophenol (2 equiv.), 4-(2'-hydroxyphenyl)-7-chloroquinoline and 4-(4'-hydroxyphenyl)-7-chloroquinoline, respectively, were formed. CSIRO 2007.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 5431-39-0